54gene Company

54gene is a healthcare startup unlocking the African genome to fuel genetic research and development that may lead to new discoveries and benefit all populations. 54gene was founded in 2019 by Dr. Abasi Ene-Obong to address the significant gap in the global genomics market: Nearly 90% of genetic material used in pharmaceutical research is caucasian. Only 2% is African, despite the fact that Africans and people of African ancestry are more genetically diverse than all other world populations combined. As a result, pharmaceutical research and development is lacking the diverse data that may hold the key to medical discoveries and new healthcare solutions.
Technology: AI
Industry: Health Care
Headquarters: San Francisco, California, United States
Founded Date: 2019-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 14
Total Funding: $19.5M
Last Funding Type: Series A

Visit Website
hello@54gene.com
https://twitter.com/weare54gene/
Register and Claim Ownership